These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37225547)

  • 1. Hydroxocobalamin in Refractory Vasodilatory Shock: More Questions than Answers.
    Kumar N; Rahman GR; Falkson S; Lu SY; Dalia A
    J Cardiothorac Vasc Anesth; 2023 Sep; 37(9):1773-1775. PubMed ID: 37225547
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of refractory shock with vitamin B
    Wedemire C; Samavat H; Newkirk M; Parker A
    Nutr Clin Pract; 2024 Apr; 39(2):356-365. PubMed ID: 38030578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxocobalamin for Vasodilatory Hypotension in Shock: A Systematic Review With Meta-Analysis for Comparison to Methylene Blue.
    Brokmeier HM; Seelhammer TG; Nei SD; Gerberi DJ; Mara KC; Wittwer ED; Wieruszewski PM
    J Cardiothorac Vasc Anesth; 2023 Sep; 37(9):1757-1772. PubMed ID: 37147207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter to the editor: Effects of a single bolus of hydroxocobalamin on hemodynamics in vasodilatory shock.
    Vollmer NJ; Seelhammer TG; Wittwer ED; Nabzdyk CG; Nei SD
    J Crit Care; 2022 Oct; 71():154046. PubMed ID: 35472601
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of Refractory Vasodilatory Shock.
    Jentzer JC; Vallabhajosyula S; Khanna AK; Chawla LS; Busse LW; Kashani KB
    Chest; 2018 Aug; 154(2):416-426. PubMed ID: 29329694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catecholamine Refractory Vasodilatory Shock: Can Therapy Become Patient Specific?
    Ortoleva JP; French AL; Dalia AA
    J Cardiothorac Vasc Anesth; 2020 Jul; 34(7):1994-1995. PubMed ID: 32151509
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of Hydroxocobalamin (Vitamin B12a) in Patients With Vasopressor Refractory Hypotension After Cardiopulmonary Bypass: A Case Series.
    Armour S; Armour TK; Joppa WR; Maltais S; Nelson JA; Wittwer E
    Anesth Analg; 2019 Jul; 129(1):e1-e4. PubMed ID: 29979199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Dose IV Hydroxocobalamin (Vitamin B12) in Septic Shock: A Double-Blind, Allocation-Concealed, Placebo-Controlled Single-Center Pilot Randomized Controlled Trial (The Intravenous Hydroxocobalamin in Septic Shock Trial).
    Patel JJ; Willoughby R; Peterson J; Carver T; Zelten J; Markiewicz A; Spiegelhoff K; Hipp LA; Canales B; Szabo A; Heyland DK; Stoppe C; Zielonka J; Freed JK
    Chest; 2023 Feb; 163(2):303-312. PubMed ID: 36174744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic Agents for the Treatment of Vasodilatory Shock.
    Knotzer H; Poidinger B; Kleinsasser A
    Curr Pharm Des; 2019; 25(19):2133-2139. PubMed ID: 31272348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent.
    Argenziano M; Chen JM; Choudhri AF; Cullinane S; Garfein E; Weinberg AD; Smith CR; Rose EA; Landry DW; Oz MC
    J Thorac Cardiovasc Surg; 1998 Dec; 116(6):973-80. PubMed ID: 9832689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of vasopressin in the treatment of vasodilation in shock states.
    Rozenfeld V; Cheng JW
    Ann Pharmacother; 2000 Feb; 34(2):250-4. PubMed ID: 10676834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II in Vasodilatory Shock.
    Wakefield BJ; Busse LW; Khanna AK
    Crit Care Clin; 2019 Apr; 35(2):229-245. PubMed ID: 30784606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxocobalamin in the treatment of vasodilatory shock.
    Carullo PC; Al-Khafaji A
    J Clin Anesth; 2020 May; 61():109665. PubMed ID: 31864779
    [No Abstract]   [Full Text] [Related]  

  • 14. Arginine vasopressin in vasodilatory shock.
    Fuchs FD; Filho JW
    Circulation; 2003 Nov; 108(19):e141; author reply e141. PubMed ID: 14610004
    [No Abstract]   [Full Text] [Related]  

  • 15. [Arginine vasopressin in vasodilatory shock: a new therapy approach?].
    Dünser M; Wenzel V; Mayr AJ; Hasibeder WR
    Anaesthesist; 2002 Aug; 51(8):650-9; discussion 659-60. PubMed ID: 12391525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginine vasopressin in advanced vasodilatory shock.
    De Backer D; Creteur J; Vincent JL
    Circulation; 2003 Nov; 108(19):e142; author reply e142. PubMed ID: 14610005
    [No Abstract]   [Full Text] [Related]  

  • 17. The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock.
    Albertson TE; Chenoweth JA; Lewis JC; Pugashetti JV; Sandrock CE; Morrissey BM
    Expert Rev Clin Pharmacol; 2022 Aug; 15(8):959-976. PubMed ID: 35920615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass.
    Peyko V; Finamore M
    Am J Case Rep; 2021 Jun; 22():e930890. PubMed ID: 34143764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressin effective in reversing catecholamine-resistant vasodilatory shock.
    Lim TW; Lee S; NG KS
    Anaesth Intensive Care; 2000 Jun; 28(3):313-7. PubMed ID: 10853217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selecting a vasopressor drug for vasoplegic shock after adult cardiac surgery: a systematic literature review.
    Egi M; Bellomo R; Langenberg C; Haase M; Haase A; Doolan L; Matalanis G; Seevenayagam S; Buxton B
    Ann Thorac Surg; 2007 Feb; 83(2):715-23. PubMed ID: 17258030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.